These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals. Shimada K; Fujii T; Tsujikawa K; Anai S; Fujimoto K; Konishi N Clin Cancer Res; 2012 Oct; 18(19):5247-55. PubMed ID: 22850567 [TBL] [Abstract][Full Text] [Related]
68. BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis. Pelekanou V; Notas G; Kampa M; Tsentelierou E; Stathopoulos EN; Tsapis A; Castanas E PLoS One; 2013; 8(12):e83250. PubMed ID: 24376672 [TBL] [Abstract][Full Text] [Related]
69. Role of the TWEAK/Fn14 pathway in autoimmune diseases. Xu WD; Zhao Y; Liu Y Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091 [TBL] [Abstract][Full Text] [Related]
70. The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion. Cheng E; Whitsett TG; Tran NL; Winkles JA Mol Cancer Res; 2015 Mar; 13(3):575-83. PubMed ID: 25392346 [TBL] [Abstract][Full Text] [Related]
72. A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Jain M; Jakubowski A; Cui L; Shi J; Su L; Bauer M; Guan J; Lim CC; Naito Y; Thompson JS; Sam F; Ambrose C; Parr M; Crowell T; Lincecum JM; Wang MZ; Hsu YM; Zheng TS; Michaelson JS; Liao R; Burkly LC Circulation; 2009 Apr; 119(15):2058-68. PubMed ID: 19349318 [TBL] [Abstract][Full Text] [Related]
73. TWEAK and the central nervous system. Yepes M Mol Neurobiol; 2007 Jun; 35(3):255-65. PubMed ID: 17917114 [TBL] [Abstract][Full Text] [Related]
74. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. Vince JE; Chau D; Callus B; Wong WW; Hawkins CJ; Schneider P; McKinlay M; Benetatos CA; Condon SM; Chunduru SK; Yeoh G; Brink R; Vaux DL; Silke J J Cell Biol; 2008 Jul; 182(1):171-84. PubMed ID: 18606850 [TBL] [Abstract][Full Text] [Related]
76. Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation. Wilhelm A; Shepherd EL; Amatucci A; Munir M; Reynolds G; Humphreys E; Resheq Y; Adams DH; Hübscher S; Burkly LC; Weston CJ; Afford SC J Pathol; 2016 May; 239(1):109-21. PubMed ID: 26924336 [TBL] [Abstract][Full Text] [Related]
77. Out of the TWEAKlight: Elucidating the Role of Fn14 and TWEAK in Acute Kidney Injury. Sanz AB; Ruiz-Andres O; Sanchez-Niño MD; Ruiz-Ortega M; Ramos AM; Ortiz A Semin Nephrol; 2016 May; 36(3):189-98. PubMed ID: 27339384 [TBL] [Abstract][Full Text] [Related]
78. Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis. Peng QL; Shu XM; Tian XL; Lu X; Wang GC Arthritis Res Ther; 2014 Jan; 16(1):R26. PubMed ID: 24467773 [TBL] [Abstract][Full Text] [Related]
79. The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson's disease. Mustafa S; Martin HL; Burkly L; Costa A; Martins ML; Schwaninger M; Teismann P Neuroscience; 2016 Apr; 319():116-22. PubMed ID: 26808775 [TBL] [Abstract][Full Text] [Related]